Medical devices, healthcare technology and the business of care
510(k) clearance · K260652

ColActive Plus

Covalon Technologies, Ltd. · Decision date Sep 9, 2026

MEDTECHLEDGER EXPLANATIONK260652

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for ColActive Plus, a collagen matrix dressing from Covalon Technologies, Ltd., under 510(k) K260652. The agency page lists a decision date of 09/09/2026 and a receipt date of 02/27/2026, while the clearance letter itself is dated September 9, 2026 and cites a submission dated August 7, 2026 and received August 10, 2026; the source does not reconcile these dates. SESE is a clearance finding, not premarket approval.

The subject device is a sterile, single-use absorbent dressing of fish-skin collagen gelatin with sodium alginate, CMC and EDTA, cleared for adult full- and partial-thickness wounds. Its listed predicate is ColActive Collagen Wound Dressing (K050177), product code KGN. The summary describes differences in collagen animal source, added materials, sterilization method, a larger 7 x 7 inch size and a 7-day maximum duration of use versus no stated limit for the predicate. The summary states that bench, animal and clinical testing were used to assess these differences, but the supplied excerpts do not report results, and the review panel is listed as General & Plastic Surgery while the specialty field is Unknown.

The source does not state whether the device is prescription or over-the-counter, and the indications text is limited to the enclosure as provided.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Unknown
Decision date
Sep 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260652
Regulatory pathway
510(k) premarket notification
Product code
KGN
Decision code
SESE
Decision date
Sep 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wound Dressing With Animal-Derived Material(S).

Product code
KGN
FDA device class
U

FDA decision timeline

  1. K260652 received

    Application receipt date recorded by FDA.

  2. K260652 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KGN

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Covalon Technologies, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mississauga

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records